Please login to the form below

Not currently logged in

EFPIA looks to ABPI for comms director

Andrew Powrie-Smith will join EU pharma trade body in New Year
Andrew Powrie-Smith

Andrew Powrie-Smith has left his role at the Association of the British Pharmaceutical Industry (ABPI) to join its European equivalent as communications director.

Powrie-Smith replaces Liam English in the role at the European Federation of Pharmaceutical Industries and Associations (EFPIA), who left the role just five months after joining in May 2014 to move back to the UK. He is now working at the ABPI on a communication project for Stephen Whitehead, CEO of the ABPI.

Powrie-Smith is currently director of the ABPI's operations in Scotland and also heads the trade body's Trust and Reputation network.

He has great experience in the not-for-profit sector, including a spell as director of the British Lung Foundation, where he campaigned to improve clinical standards in respiratory disorders, as well as positions at the British Red Cross, Amnesty International and Scope. 

Commenting on his new role, Powrie-Smith said: "I am delighted to be joining the team at EFPIA. Our industry faces some unprecedented challenges across a range of issues, but I am passionate about the story we have to tell and the difference we make to the lives of patients and their families, right across Europe.”

3rd December 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...